Offer - Urjas Oil for just ₹ 1 X
Triolmesar 40 Tablet is a prescription drug, available for use as Tablet. Secondary and off-label uses of Triolmesar 40 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Triolmesar 40 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Triolmesar 40 Tablet are Upper respiratory tract infection. While these are the most often observed Triolmesar 40 Tablet side effects, there are can be others also. These have been listed below. These side effects of Triolmesar 40 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Triolmesar 40 Tablet's effect is Safe during pregnancy and Safe for lactating mothers. In addition, Triolmesar 40 Tablet's effects on the liver, heart and kidney are discussed below in the Triolmesar 40 Tablet related warnings section.
Triolmesar 40 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) are examples of such conditions. Some other conditions that can be affected by Triolmesar 40 Tablet are listed in the contraindications section below.
Drug interactions for Triolmesar 40 Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Triolmesar 40 Tablet is not safe while driving, and is not addiction.
Triolmesar 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triolmesar 40 Tablet safe for pregnant women?
Pregnant women can take Tri Olmesar without worrying about any side effects.
Is the use of Triolmesar 40 Tablet safe during breastfeeding?
Tri Olmesar is safe for breastfeeding women.
What is the effect of Triolmesar 40 Tablet on the Kidneys?
Tri Olmesar has very mild side effects on the kidneys.
What is the effect of Triolmesar 40 Tablet on the Liver?
Tri Olmesar may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Triolmesar 40 Tablet on the Heart?
Tri Olmesar is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Triolmesar 40 Tablet unless your doctor advises you to do so -
Is this Triolmesar 40 Tablet habit forming or addictive?
Forming a habit of Triolmesar 40 Tablet has not been reported.
Interaction between Food and Triolmesar 40 Tablet
Taking Triolmesar 40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Triolmesar 40 Tablet
Consuming Triolmesar 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448